Abad A. Nadeem

Mr. Abad A. Nadeem


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Sustainability
Verified
Journal Article
Open access
PDF file
Jahangir KhanJahangir Khan
Jahangir Khan
SKshazia khurshid
shazia khurshid
Abid SarwarAbid Sarwar
Abid Sarwar
Tariq AzizTariq Aziz
Tariq Aziz
MNMuhammad Naveed
Muhammad Naveed
Monica TrifMonica Trif
Monica Trif
The foremost wastage of bakery products which mainly disturbs the food supply chain, especially in remote areas, is fungal growth. Good quality bread, especially with good height and volume, is the demand of every customer. Here, we aimed to develop a unique antimicrobial approach for the enhancement of the quality aspects and longevity of bread, using the synthesis of hydrogen peroxide in bread, the glucose oxidase (GOx) bioactivity, and oxidation of thiol protein bonds, which greatly enhance dough rheology, volume, and height by providing structural stability to the bread. An Aspergillus niger-purified enzyme was immobilized on zinc oxide nanoparticles (ZnONPs) and afterwards immersed in a buffered solution to create a mixture of GOx/ZnONPs. Analyses conducted after localization revealed that the immobilized enzyme was more active than the mobilized enzyme. GOx/ZnONPs were employed in the mixing process of bread production. The treated and control groups were evaluated for dough rheology and quality metrics including bread height and volume and storage at ambient temperature and conditions to determine shelf life by demonstrating fungal growth. In addition, antimicrobial activity was evaluated by measuring the microbiological load in terms of colony-forming units. Contrary to the control, the use of GOx/ZnONPs significantly improved bread quality, particularly bread height by 34.4%, crumb color, and volume by 30%. The shelf life of bread treated with GOx/ZnONPs was greatly extended, and the microbiological load, including yeast and mold, and total bacterial count were much lower in the GOx/ZnONPs treatment group than in the control group.

26 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Tariq AzizTariq Aziz
Tariq Aziz
ANAbad A. Nadeem
Abad A. Nadeem
Abid SarwarAbid Sarwar
Abid Sarwar
IPISHRAT PERVEEN
ISHRAT PERVEEN
NHNageen Hussain
Nageen Hussain
Lin LinLin Lin
Lin Lin
Aging is a multifunctional physiological manifestation. The nasal cavity is considered a major site for easy and cost-effective drug and vaccine administration, due to high permeability, low enzymatic activity, and the presence of a high number of immunocompetent cells. This review article primarily focuses on aging genetics, physical parameters, and the use of nanoparticles as delivery systems of drugs and vaccines via the nasal cavity. Studies have identified various genes involved in centenarian and average-aged people. VEGF is a key mediator involved in angiogenesis. Different therapeutic approaches induce vascular function and angiogenesis. FOLR1 gene codes for folate receptor alpha protein that helps in regulating the transport of vitamin B folate, 5-methyltetrahydrofolate and folate analogs inside the cell. This gene also aids in slowing the aging process down by cellular regeneration and promotes healthy aging by reducing aging symptoms. It has been found through the literature that GATA 6, Yamanaka factors, and FOLR1 work in synchronization to induce healthy and delayed aging. The role and applications of genes including CBS, CISD, SIRT 1, and SIRT 6 play a significant role in aging.

24 January 2024
Verified
Book Chapter
Open access
PDF file
IPISHRAT PERVEEN
ISHRAT PERVEEN
BBBakhtawar Bukhari
Bakhtawar Bukhari
NANaaz Abbas
Naaz Abbas
SMSania Mazhar
Sania Mazhar
YSYasar Saleem
Yasar Saleem
SSSaba Sabahat
Saba Sabahat
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has been considered responsible for the prolonged continuation of the coronavirus disease 2019 (COVID-19) pandemic. The fast dissemination of these variants presents a challenge for current vaccines. Next-generation vaccinations must be manufactured and distributed quickly to stop the pandemic. To combat existing variations and stop the development of new ones, coordinated surveillance, the designing of new vaccines, and broad-scale immunization are required. Clinical trials are still being conducted to assess the efficacy of the vaccination against various SARS-CoV-2 variants.